Efforts by the medical community to designate severe IgA nephropathy as a rare disease to improve patient access to treatment ...

Kolon TissueGene's osteoarthritis cell and gene therapy candidate TG-C (formerly Invossa) has failed to meet its co-primary ...

GC Biopharma said Friday that it will submit later in the day an investigational new drug (IND) application to the Ministry ...

HLB, a Korean cancer drug developer, said Friday that it has completed a late-cycle meeting with the U.S. FDA as part of the ...

Samsung Biologics said July 23 that it recorded revenue of 1.32 trillion won ($893.1 million) and operating profit of 586.4 ...

Oscotec Inc. has completed the inheritance process following the death of its founder and former Chairman Kim Jung-geun, with ...

Hanmi Pharmaceutical said Friday it has developed a proprietary AI platform capable of predicting the pharmacological ...

It was 2 a.m., and a patient's family member heard the same answer for the third time in a regional emergency ...

Korea will launch a government-led initiative in the second half of this year to establish evidence-based standards for ...

Researchers at Seoul National University Hospital (SNUH) have uncovered how the EZH1 Q571R mutation, a genetic alteration ...

Coffee, one of the world's most popular beverages, has long been surrounded by a variety of health claims.One of the most ...

Korean neurologists called for an overhaul of the country’s brain care system, warning that advances in treatments for ...